Related Experiment Videos
Niemann-Pick disease: a genetic model in Siamese cats
Science (New York, N.Y.)
|June 27, 1980
Summary
Three Siamese cats developed a neurological disorder due to a total deficiency in lysosomal sphingomyelinase, mirroring Niemann-Pick disease type A in feline models.
Area of Science:
- Veterinary Neurology
- Biochemistry
- Genetics
Background:
- Siamese cats presented with progressive neurological deficits starting at 4-5 months of age.
- Affected cats exhibited elevated GM2 and GM3 gangliosides in the brain and excessive sphingomyelin and cholesterol in the liver.
Purpose of the Study:
- To investigate the biochemical basis of a novel neurological disease in Siamese cats.
- To determine if the feline disease shares characteristics with human lysosomal storage disorders.
Main Methods:
- Biochemical analysis of ganglioside, sphingomyelin, and cholesterol levels in brain and liver tissues.
- Enzyme activity assays for lysosomal (pH 5.0) and microsomal (pH 7.4) sphingomyelinase in leukocytes, liver, and brain.
Main Results:
- A complete absence of lysosomal sphingomyelinase activity was detected in leukocytes, liver, and brain.
- Microsomal sphingomyelinase activity in the brain remained within normal levels.
- Accumulation of specific lipids (GM2, GM3 gangliosides, sphingomyelin, cholesterol) confirmed metabolic dysfunction.
Conclusions:
- The feline neurological disease is characterized by a total deficiency of lysosomal sphingomyelinase.
- These findings strongly suggest the disease is a genetic condition identical to Niemann-Pick disease type A.
- This feline model offers a valuable resource for studying Niemann-Pick disease type A pathogenesis and potential therapies.